251 related articles for article (PubMed ID: 22458357)
1. Orofacial diseases in solid organ and hematopoietic stem cell transplant recipients.
Petti S; Polimeni A; Berloco PB; Scully C
Oral Dis; 2013 Jan; 19(1):18-36. PubMed ID: 22458357
[TBL] [Abstract][Full Text] [Related]
2. Oral lesions in organ transplant patients.
Seymour RA; Thomason JM; Nolan A
J Oral Pathol Med; 1997 Aug; 26(7):297-304. PubMed ID: 9250928
[TBL] [Abstract][Full Text] [Related]
3. Oral malignancies following HSCT: graft versus host disease and other risk factors.
Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
[TBL] [Abstract][Full Text] [Related]
4. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation.
da Fonseca MA; Hong C
Pediatr Dent; 2008; 30(2):98-104. PubMed ID: 18481573
[TBL] [Abstract][Full Text] [Related]
5. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
Fabiani S; Fortunato S; Petrini M; Bruschi F
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
[TBL] [Abstract][Full Text] [Related]
7. [Prophylaxis against Epstein Barr disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
Catalán P; Alba A
Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S29-31. PubMed ID: 23282553
[TBL] [Abstract][Full Text] [Related]
8. Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen.
Gürgan CA; Özcan M; Karakuş Ö; Zincircioğlu G; Arat M; Soydan E; Topcuoglu P; Gürman G; Bostancı HS
Int J Dent Hyg; 2013 May; 11(2):84-90. PubMed ID: 22487659
[TBL] [Abstract][Full Text] [Related]
9. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation.
Brand HS; Bots CP; Raber-Durlacher JE
Br Dent J; 2009 Nov; 207(9):E17; discussion 428-9. PubMed ID: 19893563
[TBL] [Abstract][Full Text] [Related]
10. Solid organ transplants following hematopoietic stem cell transplant in children.
Bunin N; Guzikowski V; Rand ER; Goldfarb S; Baluarte J; Meyers K; Olthoff KM
Pediatr Transplant; 2010 Dec; 14(8):1030-5. PubMed ID: 20846242
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.
Chong PP; Avery RK
Clin Ther; 2017 Aug; 39(8):1581-1598. PubMed ID: 28751095
[TBL] [Abstract][Full Text] [Related]
12. Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes.
Pilie P; Werbel WA; Riddell J; Shu X; Schaubel D; Gregg KS
Transpl Infect Dis; 2015 Aug; 17(4):551-7. PubMed ID: 26059180
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia.
Moon SM; Sung H; Kim MN; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
Transpl Infect Dis; 2012 Apr; 14(2):192-7. PubMed ID: 22260384
[TBL] [Abstract][Full Text] [Related]
15. Oral lesions in Saudi renal transplant patients.
Al-Mohaya MA; Darwazeh AM; Bin-Salih S; Al-Khudair W
Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):20-9. PubMed ID: 19112215
[TBL] [Abstract][Full Text] [Related]
16. Oral Lesions in Kidney Transplant Recipients.
Levarda-Hudolin K; Hudolin T; Bašić-Jukić N; Kaštelan Ž
Acta Clin Croat; 2016 Sep; 55(3):459-463. PubMed ID: 29045773
[TBL] [Abstract][Full Text] [Related]
17. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
18. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
19. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients.
Doucette K; Fishman JA
Clin Infect Dis; 2004 May; 38(10):1428-39. PubMed ID: 15156482
[TBL] [Abstract][Full Text] [Related]
20. Risk of Subsequent Vitiligo in Transplant Recipients With Comorbid Graft-vs-Host Disease.
Bang CH; Park HE; Kim YH; Jung JH; Lee JH; Park YM; Han JH
JAMA Dermatol; 2024 Feb; 160(2):194-198. PubMed ID: 38091023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
